
DSC Investment
Description
DSC Investment is a prominent venture capital firm based in Seoul, South Korea, established in 2009. As a publicly listed company on the KOSDAQ stock exchange (stock code 241520), it holds a significant and transparent position within the Korean venture ecosystem. The firm is recognized for its strategic investments in early-stage and growth companies, playing a crucial role in fostering innovation across various high-growth sectors. DSC Investment has built a strong reputation for identifying and nurturing promising startups, contributing significantly to their scaling and market penetration.
The firm's investment strategy primarily targets companies in the IT, software, biotechnology, and new materials sectors. DSC Investment typically engages in seed, Series A, and Series B funding rounds, though it also participates in later-stage growth equity. Their approach involves not just capital injection but also providing strategic guidance and leveraging their extensive network to support portfolio companies. They seek out startups with strong technological foundations, innovative business models, and high growth potential, aiming to create long-term value.
With assets under management (AUM) approaching ₩1 trillion (approximately $750 million USD), DSC Investment manages a diverse portfolio of over 20 venture funds. These funds are strategically deployed to support a wide array of startups, from nascent ideas to established growth companies. Notable investments include leading companies in the AI healthcare and biotech space, such as Lunit and VUNO, demonstrating their capability to back market leaders. Their commitment to fostering a vibrant startup ecosystem is evident through their consistent investment activity and their role in numerous successful exits.
DSC Investment's robust financial standing and deep industry expertise make it a key player in the South Korean venture capital landscape. Their focus on early-stage innovation, combined with their capacity for substantial follow-on investments, positions them as a preferred partner for ambitious entrepreneurs. The firm continues to be a driving force behind technological advancement and economic growth in South Korea, consistently seeking out the next generation of disruptive companies.
Investor Profile
DSC Investment has backed more than 61 startups, with 16 new investments in the last 12 months alone. The firm has led 9 rounds, about 15% of its total and boasts 10 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Seed, Series B rounds (top funding stages).
- Majority of deals are located in South Korea, United States, Israel.
- Strong thematic focus on Artificial Intelligence (AI), Health Care, Biotechnology.
- Led 7 rounds in the past year.
- Typical check size: $500K – $7M.
Stage Focus
- Series A (33%)
- Seed (28%)
- Series B (25%)
- Series C (8%)
- Series Unknown (5%)
- Secondary Market (2%)
Country Focus
- South Korea (70%)
- United States (25%)
- Israel (3%)
Industry Focus
- Artificial Intelligence (Ai)
- Health Care
- Biotechnology
- E-commerce
- Software
- Manufacturing
- Machine Learning
- Medical
- Medical Device
- Information Technology
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.